Physician profile
Milan Jansky
NPI 1598748428
$1,676.74
in general payments reported to CMS, 2019-2025
13 companies · $408 in 2025
The $408 reported for 2025 was more than what 75% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $19.96 · 2021: $27.09 · 2022: $107 · 2023: $171 · 2024: $509 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,087.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $388.10 | 2019-2025 | Watchman Flx |
| Smith+Nephew, INC. | $264.12 | 2019-2020 | |
| Abbott Laboratories | $155.08 | 2022-2023 | Mitraclip, Supera |
| Biosense Webster, INC. | $146.52 | 2024 | Carto 3 |
| Kerecis Limited | $137.44 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Stryker Corporation | $129.58 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $123.83 | 2025 | |
| Mimedx Group, INC. | $100.49 | 2024 | |
| Kci USA, INC. | $94.73 | 2023 | Activ.A.C. |
| Organogenesis INC. | $61.45 | 2019-2025 | Affinity, Puraply |
| Osiris Therapeutics INC. | $34.59 | 2019 | |
| Glaxosmithkline, LLC. | $27.94 | 2021-2022 | |
| Becton, Dickinson and Company | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milan Jansky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.